FDA's Final PRO Guidance Grounds Policy With More Details
This article was originally published in The Pink Sheet Daily
Executive Summary
Issued in December, the final guidance explains "content validity," and advises sponsors to use target product profiles and to document that patient input informed PRO instrument development.